Item 7.01. Regulation FD Disclosure.
On March 31, 2020, Amgen Inc. posted on its website at
https://www.amgen.com/media/our-perspective/amgen-update-regarding-covid-19/ an
Amgen Update Regarding COVID-19 for Media (the "COVID-19 Perspective"). A copy
of the COVID-19 Perspective is attached hereto as Exhibit 99.1 and incorporated
into this Item 7.01 by reference. The information contained in this Item 7.01
and Exhibit 99.1 shall not be deemed to be "filed" for the purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liabilities of such section, nor will such
information be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as may be
expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
d) Exhibits
Exhibit
No. Description
99.1 Amgen Update Regarding COVID-19 for Media, dated March 31, 2020.
104 Cover Page Interactive File (the cover page tags are embedded within
the Inline XBRL document).
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses